Dispersion Delivery TRIZ Cases

Inhaled fluid with pH below 3.0 targets respiratory pathogens via acid-mediated disruption, offering broad-spectrum efficacy without systemic toxicity.

GM-ACT leaves provide high-activity oxalate oxidase to reduce oxalate levels in tea, mitigating kidney stone risk without altering beverage consumption.

VHH antibodies target the spike protein receptor-binding domain to neutralize SARS-CoV-2 variants while reducing production costs.

A nasal hepatitis B vaccine composition utilizes a gel base material treated with outside shearing force to enhance spray performance.

Micronized glycerol emulsions overcome powder clumping to ensure stable storage and reliable dosing.

Miraculin adjusts pH to reduce perceived saltiness, resolving the trade-off between cleansing efficacy and patient compliance.

Ultrasonic treatment with medium-chain triglycerides solubilizes cannabinoids without harmful emulsifiers, ensuring safe long-term bioavailability.

A powder formulation combines activated charcoal with B vitamins and herbal extracts to create an effervescent therapeutic liquid.

HFA-152a replaces high-GWP propellants to maintain chemical stability and ambient shelf life for tiotropium formulations.

Low-heat dried sugarcane fibre binds excess stomach acid and reduces gastric pressure, resolving side effects from conventional medications.

Pico size carbon particles buffer aqueous CBD to pH 7.5-9.5, preventing hydroquinone formation and ensuring long-term stability.

Extracting key ingredients from eleven-ingredient formulas cuts volume and cost while maintaining efficacy.

Periodic aqueous sodium bicarbonate administration thins mucus via osmosis, avoiding vasoconstrictor side effects like drowsiness.

Novel capsaicinoid compounds inhibit the HIV capsid protein, overcoming multidrug resistance and reducing viral load in heavily treated patients.

A sterile culturing method for fresh Chlorella drink production using rapid cooling and controlled freezing to preserve cell integrity.

Macrocyclic peptides lower c-Myc protein levels, overcoming hormonal therapy resistance in prostate and breast cancer models.

A ruthenium catalyst system mediates hydrogen-deuterium exchange between ethanol and heavy water using a co-solvent.

Enzymes break down plant cell walls to improve extraction efficiency while reducing harsh solvent use and production costs.

Nasal curcumin-arginine composition overcomes low bioavailability by converting to nitric oxide locally.

A whey protein hydrolysate enriched in tolerogenic peptides via ultrafiltration using an intermediary additive.

TPGS surfactant improves nebulization output of mRNA lipid nanoparticles without increasing particle size or reducing encapsulation efficiency.

Topical or oral kale formulations selectively destroy tumor cells via local quality and parameter changes, reducing systemic toxicity.

Benzaldehyde carrier compositions address formulation complexity by enabling broad-spectrum effectiveness through adjustable concentration ranges.

A choline and succinate composition enhances mitochondrial energy production to improve skeletal muscle strength and tone.

An RPS2 polypeptide composition reduces blood glucose, pressure, and cholesterol simultaneously, eliminating the side effects of combination drug therapies.

Tangential ultrafiltration retains salts within phospholipid liposomes, improving taste and absorption without high glucose.

Optimized sodium sulfate particle size prevents hygroscopic mouth feel and hard mass formation, enabling versatile dual-use tablet administration.

An inhaler system delivers controlled ratios of active substances using dynamic heating and airflow profiles.

A floating interpenetrating polymer network entraps gamma-hydroxybutyrate and gas to sustain drug release in the stomach.

Amphiphilic dendrimers stabilize perfluorocarbon nanoemulsions to enable ultrasound-triggered drug release, resolving gadolinium toxicity risks.

L-tartaric acid lowers pH below 3.5 in valganciclovir powder, resolving solubility and stability trade-offs while extending shelf life.

Nitrogen-inerted syrup processing prevents oxidation losses, maintaining precise vitamin ratios without overdosing.

A composite emulsifier system combines phospholipids with sucrose fatty acid esters to enhance in vivo absorbability of lipophilic ingredients.

Selective pyrimidinecarboxamide inhibitors suppress tumor angiogenesis and neutrophil recruitment by blocking CXCR1/2 receptor activity.

A dual-chamber pack replaces breakable membranes with a flexible diaphragm to prevent contamination and ensure stable drug mixing.

Vibrating mesh inhalers deliver exenatide via pulmonary absorption, enabling flexible dose titration to reduce injection side effects.

Patsnap Eureka analyzes a cranberry extract concentrate providing stable red coloring in pharmaceutical preparations.

Merging cannabinoids with xanthines overcomes low bioavailability and slow action speed to deliver rapid nootropic effects.

Synthetic extraction yields high purity cannabidiol for stable lipid-based pharmaceutical formulations.

A buffered aqueous liquid with pH 10 to 11.5 neutralizes chemotherapy-induced acid, reducing side effects without additional medications.

UreaAide sparkling powder masks urea taste with agave and citrus flavorings, improving patient adherence for hyponatremia treatment.

Liposomes functionalized with integrin targeting agents bind specifically to alpha4beta1-expressing cells.

Dynamic spray control adjusts angle and pressure to target specific nasal regions, addressing the trade-off between localized precision and device complexity.

Buffered ALV003 enzymes degrade ingested gluten to prevent mucosal injury, overcoming strict dietary adherence challenges.

Topical polymer formulations transition to a gel at physiological temperatures to stop gastrointestinal bleeding while avoiding systemic side effects.

Combining pterostilbene with megestrol acetate enhances antiproliferative effects against endometrial cancer cells.

Xanthan gum stabilizes micronized diosmin suspension viscosity to prevent sedimentation and improve patient compliance.

Standardized platelet dry powder resolves quality inconsistency in respiratory treatments while maintaining high growth factor recovery during nebulization.